Drug-drug interactions in the metabolism of imidafenacin: Role of the human cytochrome P450 enzymes and UDP-glucuronic acid transferases, and potential of imidafenacin to inhibit human cytochrome P450 enzymes

By Kanayama N.   Kanari C.   Masuda Y.   Ohmori S.   Ooie T.  

Xenobiotica, Vol. 37, Iss. 2, 2007-02 ,pp. : 139-154

Informa Healthcare

Access to resources Recommend Favorite

Evaluation of cytochrome P450-mediated drug–drug interactions based on the strategies recommended by regulatory authorities

By Kosugi Yohei   Hirabayashi Hideki   Igari Tomoko   Fujioka Yasushi   Hara Yoko   Okuda Teruaki   Moriwaki Toshiya  

Xenobiotica, Vol. 42, Iss. 2, 2012-02 ,pp. : 127-138

Informa Healthcare

Access to resources Recommend Favorite

In vitro assessment of metabolic drug–drug interaction potential of AZD2624, neurokinin-3 receptor antagonist, through cytochrome P₄₅₀ enzyme identification, inhibition, and induction studies

By Li Yan   Zhou Diansong   Ferguson Stephen S.   Dorff Peter   Simpson Thomas R.   Grimm Scott W.  

Xenobiotica, Vol. 40, Iss. 11, 2010-11 ,pp. : 721-729

Informa Healthcare

Access to resources Recommend Favorite

Mechanism-based inactivation of human cytochrome P450 enzymes: strategies for diagnosis and drug–drug interaction risk assessment

By Venkatakrishnan K.   Obach R. S.   Rostami-Hodjegan A.  

Xenobiotica, Vol. 37, Iss. 10-11, 2007-11 ,pp. : 1225-1256

Informa Healthcare

Access to resources Recommend Favorite

The utility of cold-preserved human hepatocytes in studies on cytochrome P450 induction and hepatic drug transport

By Juric Sanja  

Xenobiotica, Vol. 43, Iss. 9, 2013-09 ,pp. : 785-791

Informa Healthcare

Access to resources Recommend Favorite